The role of monocytes in atherosclerotic coronary artery disease

Annals of Medicine

Volumn 42, Issue 6, 2010, Pages 394-403

  Pamukcu, Burak ^a   Lip, Gregory Y H ^a,b   Devitt, Andrew ^b   Griffiths, Helen ^b   Shantsila, Eduard ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

Atherosclerosis; Innate immunity; Monocytes

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; COLONY STIMULATING FACTOR 1; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FRACTALKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPID; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; RANTES; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CELL ADHESION; CELL MIGRATION; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; HUMAN; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; TISSUE REGENERATION; VASCULAR ENDOTHELIUM;

ANIMALS; ATHEROSCLEROSIS; BLOOD PLATELETS; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; LIPID METABOLISM; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 77955130598     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.497767     Document Type: Review

References (108)

1. Napoli C, D ' Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxdation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100: 2680-2690
2. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. A defi nition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Atherosclerosis, American Heart Association. Circulation. 1994;89: 2462-2478 (Pubitemid 24142837)
3. Ross R. The pathogenesis of atherosclerosis\an update. N Engl J Med. 1986;314:488-500.
4. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138
5. Elsheikh E, Uzunel M, He Z, Holgersson J, Nowak G, Sumitran-Holgersson S. Only specific subtype of human peripheral blood monocytes has endothelial-like functional capacity. Blood. 2005;106:2347-2355
6. Shantsila E, Lip GY. Monocytes in acute coronary syndromes. Arterioscler Thromb Vasc Biol. 2009;29:1433-1438
7. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216.
8. Kantari C, Pederzoli-Ribeil M, Witko-Sarsat V. The role of neutrophils and monocytes in innate immunity. Contrib Microbiol. 2008;15:118-146
9. Monie TP, Bryant CE, Gay NJ. Activating immunity: lessons from the TLRs and NLRs. Trends Biochem Sci. 2009;34: 553-561
10. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1:135-145
11. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007;130:1071-1082
12. Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007;130:906-917
13. Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM, et al. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science. 2008;320:379-381
14. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009;458:1191-1195
15. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085-2088
16. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice defi cient in apolipoprotein E. Proc Natl Acad Sci USA. 2004;101:10679-10684
17. Methe H, Kim JO, Kofl er S, Weis M, Nabauer M, Koglin J. Expansion of circulating Toll-like receptor 4-positive mono-cytes in patients with acute coronary syndrome. Circulation. 2005;111:2654-2661
18. Orihara K, Nagata K, Hamasaki S, Oba R, Hirai H, Ishida S, et al. Time-course of Toll-like receptor 2 expression, as a predictor of recurrence in patients with bacterial infectious diseases. Clin Exp Immunol. 2007;148:260-270
19. Kajiya T, Orihara K, Hamasaki S, Oba R, Hirai H, Nagata K, et al. Toll-like receptor 2 expression level on monocytes in patients with viral infections: monitoring infection severity. J Infect. 2008;57:249-259
20. Mizoguchi E, Orihara K, Hamasaki S, Ishida S, Kataoka T, Ogawa M, et al. Association between Toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina. Coron Artery Dis. 2007;18:31-38
21. Kuwahata S, Fujita S, Orihara K, Hamasaki S, Oba R, Hirai H, et al. High expression level of Toll-like receptor 2 on monocytes is an important risk factor for arteriosclerotic disease. Atherosclerosis. 2010;209:248-254
22. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem. 2002;277:15028-15034
23. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006;177: 1272-1281
24. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the tolllike receptor-4 complex. J Immunol. 2000;164:558-561
25. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002;195: 99-111.
26. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001;167:2887-2894
27. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol. 2002;168:5233-5239
28. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain A of fi bronectin activates Toll-like receptor 4. J Biol Chem. 2001;276:10229-10233
29. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 1998;392:505-509
30. Devitt A, Parker KG, Ogden CA, Oldreive C, Clay MF, Melville LA, et al. Persistence of apoptotic cells without autoimmune disease or infl ammation in CD14-/-mice. J Cell Biol. 2004;67:1161-1170
31. Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res. 2008;58:88-111.
32. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109:S81-96.
33. van den Berg R, Haenen GR, van den Berg H, Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br J Nutr. 2001;86 Suppl 1:S121-7.
34. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722
35. Zhao L, Funk CD. Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med. 2004;14:191-195
36. Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D, et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor defi cient mice. Circulation. 2002;105:1816-1823
37. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-defi cient mice. Arterioscler Thromb Vasc Biol. 1999;19:1518-1525
38. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001;107:1255-1262
39. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL. P-selectin or intercellular adhesion molecule (ICAM)-1 defi ciency substantially protects against atherosclerosis in apolipoprotein E-defi cient mice. J Exp Med. 2000;191:189-194
40. Brach MA, Henschler R, Mertelsmann RH, Herrmann F. Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF kappa B. Pathobiology. 1991;59:284-288
41. Tavora FR, Ripple M, Li L, Burke AP. Monocytes and neu-trophils expressing myeloperoxidase occur in fi brous caps and thrombi in unstable coronary plaques. BMC Cardiovasc Disord. 2009;9:27.
42. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001;158:879-891
43. Hoshi S, Goto M, Koyama N, Nomoto K, Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, I-kappaB. J Biol Chem. 2000;275:883-889
44. Kanda T, Takahashi T. Interleukin-6 and cardiovascular diseases. Jpn Heart J. 2004;45:183-193
45. Ikeda U, Ito T, Shimada K. Interleukin-6 and acute coronary syndrome. Clin Cardiol. 2001;24:701-704
46. Yao L, Huang K, Huang D, Wang J, Guo H, Liao Y. Acute myocardial infarction induced increases in plasma tumor necrosis factor-alpha and interleukin-10 are associated with the activation of poly(ADP-ribose) polymerase of circulating mononuclear cell. Int J Cardiol. 2008;123:366-368
47. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008;18:228-232
48. Lukacs NW, Strieter RM, Elner V, Evanoff HL, Burdick MD, Kunkel SL. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood. 1995;86:2767-2773
49. Lundgren CH, Sawa H, Sobel BE, Fujii S. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation. 1994;90:1927-1934
50. Sirpal S. Myeloperoxidase-mediated lipoprotein carbamyla-tion as a mechanistic pathway for atherosclerotic vascular disease. Clin Sci (Lond). 2009;116:681-695
51. Vasconcelos EM, Degasperi GR, de Oliveira HC, Vercesi AE, de Faria EC, Castilho LN. Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin Biochem. 2009;42: 1222-1227
52. Speidl WS, Toller WG, Kaun C, Weiss TW, Pfaffenberger S, Kastl SP, et al. Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability. FASEB J. 2004; 18:603-605
53. Poitevin S, Garnotel R, Antonicelli F, Gillery P, Nguyen P. Type I collagen induces tissue factor expression and matrix metalloproteinase 9 production in human primary mono-cytes through a redox-sensitive pathway. J Thromb Haemost. 2008;6:1586-1594
54. Ross R. Atherosclerosis\an infl ammatory disease. N Engl J Med. 1999;340:115-126
55. Irvine KM, Andrews MR, Fernandez-Rojo MA, Schroder K, Burns CJ, Su S, et al. Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages. J Leukoc Biol. 2009;85:278-288
56. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice defi cient in both mac-rophage colony stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA. 1995;92:8264-8268
57. Combadi è re C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation. 2008;117:1649-1657
58. Hansson GK, Libby P, Schönbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 2002;91:281-291
59. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47:C7-12.
60. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translo-cation. J Clin Invest. 1995;95:2297-2303
61. van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 1992;141: 1427-1433
62. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, et al. Direct demonstration of P-selectin-and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-defi cient mice. Circ Res. 1999;84:1237-1244
63. Gerszten RE, Lim YC, Ding HT, Snapp K, Kansas G, Dichek DA, et al. Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. Circ Res. 1998;82:871-878
64. Huo Y, Weber C, Forlow SB, Sperandio M, Thatte J, Mack M, et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest. 2001;108: 1307-1314
65. von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AE, et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood. 2005;105:924-930
66. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, et al. Ly-6Chi monocytes dominate hypercho-lesterolemia-associated monocytosis and give rise to macro-phages in atheromata. J Clin Invest. 2007;117:195-205.
67. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007;117:185-194
68. Apostolakis S, Lip GY, Shantsila E. Monocytes in heart failure: Relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res. 2010; 85:649-660
69. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA. 1979;76: 333-337
70. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol. 1997;8: 275-280
71. Devitt A, Gregory CD. Innate immune mechanisms in the resolution of infl ammation. In: Rossi AG, Sawatzky DA, editors. Progress in inflammation: the resolution of inflam-mation. Basel: Birkhauser Verlag; 2008. p. 39-56.
72. de Winther MP, Gijbels MJ, van Dijk KW, van Gorp PJ, Suzuki H, Kodama T, et al. Scavenger receptor defi ciency leads to more complex atherosclerotic lesions in APOE3Lei-den transgenic mice. Atherosclerosis. 1999;144:315-321
73. Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LF, et al. Genetic background determines the extent of atherosclerosis in ApoE-defi cient mice. Arterioscler Thromb Vasc Biol. 1999;19:1960-1968
74. Teupser D, Stein O, Burkhardt R, Nebendahl K, Stein Y, Thiery J. Scavenger receptor activity is increased in macro-phages from rabbits with low atherosclerotic response: studies in normocholesterolemic high and low atherosclerotic response rabbits. Arterioscler Thromb Vasc Biol. 1999;19: 1299-1305
75. Silverstein RL, Febbraio M. CD36 and atherosclerosis. Curr Opin Lipidol. 2000;11:483-491
76. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, et al. Targeted disruption of the Class B scavenger receptor, CD36, protects against atherosclerotic lesion development in mice. J Clin Invest. 2000;105:1049-1056
77. Silverstein RL. Inflammation, atherosclerosis, and arterial thrombosis: Role of the scavenger receptor CD36. Cleve Clin J Medicine. 2009;76:S27-30.
78. Febbraio M, Guy E, Silverstein RL. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24:2333-2338
79. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA. 1997;94:12610-12615
80. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, et al. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-defi cient mice. Circ Res. 2002;90:270-276
81. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture angiogenesis as a source of intra-plaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25: 2054-2061
82. Moulton KS. Plaque angiogenesis: its functions and regulation. Cold Spring Harbor Symp Quant Biol. 2002;67: 471-482
83. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol. 2008;51:1258-1265
84. Gessi S, Fogli E, Sacchetto V, Merighi S, Varani K, Preti D, et al. Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler Thromb Vasc Biol. 2010;30:90-97
85. Fong GH. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis. 2008;11:121-140
86. Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int J Cardiol. 2008;130: 147-158
87. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butter-fi eld C, Sylvin E, et al. Inhibition of plaque neovasculariza-tion reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA. 2003; 100:4736-4741
88. Ribatti D, Levi-Schaffer F, Kovanen PT. Infl ammatory ang-iogenesis in atherogenesis\a double-edged sword. Ann Med. 2008;40:606-621
89. Murdoch C, Tazzyman S, Webster S, Lewis CE. Expression of Tie-2 by human monocytes and their responses to angi-opoietin-2. J Immunol. 2007;178:7405-7411
90. Shantsila E, Lip GY. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost. 2009;102:916-924
91. Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a non-plasmin fi brinolytic pathway. Blood. 1993;82:2414-2422
92. Arber N, Berliner S, Pras E, Arber L, Fishelson Z, Kahn Y, et al. Heterotypic leukocyte aggregation in the peripheral blood of patients with leukemia, infl ammation and stress. Nouv Rev Fr Hematol. 1991;33:251-255
93. Kaplar M, Kappelmayer J, Veszpremi A, Szabo K, Udvardy M. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets. 2001;12:419-422
94. Danenberg HD, Kantak N, Grad E, Swaminathan RV, Lotan C, Edelman ER. C-reactive protein promotes monocyte-platelet aggregation: an additional link to the infl ammatory-thrombotic intricacy. Eur J Haematol. 2007; 78:246-252
95. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol. 1998;31:352-358
96. Brambilla M, Camera M, Colnago D, Marenzi G, De Metrio M, Giesen PL, et al. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol. 2008;28:947-953
97. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, et al. Prognostic signifi cance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Car-diol. 2002;39:241-246
98. Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, et al. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol. 2000;35:968-973 (Pubitemid 30189930)
99. Iwama H, Uemura S, Naya N, Imagawa K, Takemoto Y, Asai O, et al. Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol. 2006;47:1559-1567
100. Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, et al. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol. 2009;54:130-138
101. Bruno S, Bussolati B, Scacciatella P, Marra S, Sanavio F, Tarella C, et al. Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine. 2006;34:56-65.
102. Dresske B, El Mokhtari NE, Ungefroren H, Ruhnke M, Plate V, Janssen D, et al. Multipotent cells of monocytic origin improve damaged heart function. Am J Transplant. 2006;6:947-958
103. Satoh M, Shimoda Y, Akatsu T, Ishikawa Y, Minami Y, Nakamura M. Elevated circulating levels of heat shock protein 70 are related to systemic infl ammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail. 2006;8:810-815
104. de Lemos JA, Morrow DA, Blazing MA, Jarolim P, Wiviott SD, Sabatine MS, et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol. 2007;50: 2117-2124
105. Satoh M, Shimoda Y, Maesawa C, Akatsu T, Ishikawa Y, Minami Y, et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol. 2006;109:226-234
106. Sheu JJ, Chang LT, Chiang CH, Youssef AA, Wu CJ, Lee FY, et al. Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction. Int Heart J. 2008;49:1-11.
107. Dahl CP, Gullestad L, Fevang B, Holm AM, LandrøL, Vinge LE, et al. Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure. Eur J Heart Fail. 2008;10:352-359
108. Satoh M, Iwasaka J, Nakamura M, Akatsu T, Shimoda Y, Hiramori K. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Eur J Heart Fail. 2004;6: 869-875